Denis Chem Lab Limited saw a reduction in institutional holding as VS Holding BV disposed of 2.05% of the company's equity shares via open market transactions. The seller, a non-promoter entity, executed these sales between September and October 2026, lowering its total shareholding from 16.46% to 14.41%.

The disclosure, filed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, indicates that VS Holding BV sold 284,447 equity shares. Prior to this transaction, the entity held 2,284,335 shares, all of which were free from encumbrances such as pledges or liens. The post-transaction holding stands at 1,999,888 shares.

Transaction Details

The sale was conducted entirely through the open market on the BSE Limited. The transactions occurred over a period spanning September to October 16, 2026. The total equity share capital of the company remained unchanged at ₹138.77 crore, comprising 1,38,76,668 equity shares of ₹10 each.

Holding Structure Analysis

A notable shift occurred in the nature of the holdings during this period. Before the sale, all 2,284,335 shares held by VS Holding BV were categorized under encumbrance details in the filing structure, though the specific type of encumbrance was not detailed beyond the category header. Post-sale, the remaining 1,999,888 shares are listed as unencumbered voting rights. This suggests a cleanup or release of encumbrances coinciding with the disposal of the 2.05% stake.

The acquirer does not belong to the promoter or promoter group. The transaction involved no convertible securities or voting rights acquired otherwise than by equity shares. The diluted share capital remains identical to the total voting capital, indicating no outstanding warrants or convertible instruments that would alter the denominator for percentage calculations.

Denis Chem Lab shareholders approved the re-appointment of Dr. Himanshu C. Patel as Managing Director for a period of three years, effective August 1, 2026. This decision was part of the resolutions passed at the company's 45th Annual General Meeting (AGM), held on September 25, 2026.

The re-appointment was ratified via a Special Resolution, securing 99.31% votes in favor. Dr. Patel’s tenure extends to July 31, 2029. The disclosure confirms he is not debarred from holding office by SEBI or other authorities. His prior term expired on July 31, 2026, necessitating this renewal given his continued responsibilities in the pharmaceutical sector.

Key resolutions and voting results

Shareholders transacted several agenda items via e-voting, with results declared immediately following the meeting. The approved resolutions included the adoption of audited financial statements, declaration of dividend, director re-appointments, and auditor appointments. The specific voting outcomes are detailed below:

Governance and leadership updates

The re-appointment of Dr. Himanshu C. Patel was noted with his DIN: 00087114. He holds a B.E., M.S., and Ph.D., bringing more than seven decades of experience in the medical and pharmaceutical fields. The disclosure highlights that Dr. Himanshu C. Patel, Ms. Anar H. Patel, and Mr. Dinesh B. Patel are related to each other.

Ms. Anar Patel was also re-appointed as a Director liable to retire by rotation. The Board reported no qualifications from the Statutory or Secretarial Auditors in their respective reports for the period.

Secretarial auditor appointment details

Shareholders appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five consecutive years, from FY27 to FY31. The firm is based in Ahmedabad and provides integrated legal and advisory services in Corporate Laws, Capital Markets, and Corporate Governance.

The appointment was confirmed under Regulation 30 of Listing Regulations. The disclosure notes that Yash K. Mehta, Managing Partner, has more than 15 years of post-qualification experience and has headed the private practice since its founding in 2015. The firm offers full-spectrum corporate, secretarial, regulatory, and compliance services. There are no disclosed relationships between the auditors and the Directors or the Company.

Voting participation details

Remote e-voting facilities were provided to members from September 22, 2026, to September 24, 2026. During the AGM, additional e-voting was available for attendees who had not voted remotely. A total of 42 folios participated in the voting process, representing 88,69,232 votes out of the total outstanding shares.

The AGM commenced at 12:00 pm and concluded at 12:14 pm IST. Dr. Himanshu C. Patel chaired the session as directed by Chairman Dinesh Patel.